1. Home
  2. RNXT vs ZJYL Comparison

RNXT vs ZJYL Comparison

Compare RNXT & ZJYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

N/A

Current Price

$0.88

Market Cap

36.4M

Sector

Health Care

ML Signal

N/A

Logo JIN MEDICAL INTERNATIONAL LTD.

ZJYL

JIN MEDICAL INTERNATIONAL LTD.

N/A

Current Price

$0.19

Market Cap

40.5M

ML Signal

N/A

Company Overview

Basic Information
Metric
RNXT
ZJYL
Founded
2012
2006
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
36.4M
40.5M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
RNXT
ZJYL
Price
$0.88
$0.19
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$7.75
N/A
AVG Volume (30 Days)
214.1K
138.8K
Earning Date
11-13-2025
08-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.01
Revenue
$928,000.00
$22,826,624.00
Revenue This Year
$2,795.35
N/A
Revenue Next Year
$272.69
N/A
P/E Ratio
N/A
$16.35
Revenue Growth
N/A
13.42
52 Week Low
$0.70
$0.18
52 Week High
$1.69
$1.42

Technical Indicators

Market Signals
Indicator
RNXT
ZJYL
Relative Strength Index (RSI) 44.91 25.24
Support Level $0.83 $0.18
Resistance Level $1.00 $0.24
Average True Range (ATR) 0.06 0.02
MACD 0.01 -0.00
Stochastic Oscillator 36.53 9.54

Price Performance

Historical Comparison
RNXT
ZJYL

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About ZJYL JIN MEDICAL INTERNATIONAL LTD.

Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.

Share on Social Networks: